Next-Gen Smallpox, Anthrax Vaccines To Be First Use Of Animal Efficacy
Executive Summary
A next-generation smallpox vaccine is expected to be the first product licensed under FDA's animal efficacy rule, HHS Office of the Assistant Secretary for Public Health Emergency Preparedness Senior Advisor Philip Russell, MD, said Aug. 28